This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a prescription medication. The contract has a ceiling value of $33,890.35 and an ultimate completion date of September 19, 2024. It is a firm fixed-price contract and does not have a set-aside designation. As a key supplier to various federal healthcare programs, including those...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 45 MG TABLET UU 28S. The contract has a ceiling value of $87,247.01 and a completion date of September 27, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as the primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of pharmaceutical products, including RINVOQ ER 30 MG tablets, to support federal healthcare programs. The contract has a ceiling value of $38,892.00 and a term running through January 27, 2025. The contract is a firm fixed-price delivery order, with no set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, and has a ceiling value of $6,015.42. The contract is a firm-fixed price delivery order, with a completion date of September 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to provide...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $19,794.37. The contract is for the supply of RINVOQ ER 15 MG TABLET (National Stock Number 4567157058), a pharmaceutical product. The contract has a final completion date of February 5, 2025 and is a firm fixed-price agreement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,629.01, is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 15 MG TABLET. The contract has a firm fixed price of $29,216.09 and a completion date of March 18, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,212.92, is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of February 13, 2023. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, valued at $9,334.98. The contract is for the delivery of RINVOQ ER 30 MG TABLET, a pharmaceutical product, with a completion date of January 31, 2025. The contract is a firm fixed-price type, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on this award, and the contract is part of a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product. The contract has a ceiling value of $25,857.56 and an ultimate completion date of September 25, 2024. The contract is a firm-fixed-price type, and there was no set-aside used. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by the DLA...